Compare CGC & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGC | FTHY |
|---|---|---|
| Founded | N/A | 2020 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.3M | 494.6M |
| IPO Year | 2023 | 2020 |
| Metric | CGC | FTHY |
|---|---|---|
| Price | $1.01 | $13.45 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 95.7K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.93% |
| EPS Growth | ★ 84.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,759,000.00 | N/A |
| Revenue This Year | $8.27 | N/A |
| Revenue Next Year | $15.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $13.20 |
| 52 Week High | $2.38 | $14.84 |
| Indicator | CGC | FTHY |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 45.63 |
| Support Level | $0.93 | $13.40 |
| Resistance Level | $1.08 | $13.71 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 46.24 | 62.15 |
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.